Diabetes mellitus and obesity have converged into a single, interlinked metabolic epidemic that now touches almost every health system in the world. For decades, pharmacological management of type 2 diabetes mellitus centred on glycaemic control alone, with obesity addressed sepa...
Open access
Research Article10.9734/jammr/2026/v38i86173
Pancreatic cancer remains one of the most lethal malignancies worldwide, mainly because diagnosis commonly occurs at advanced stages, tumour biology is aggressive, and responses to conventional therapies are limited. Pancreatic ductal adenocarcinoma (PDAC), which represents appro...
Open access
Research Article10.9734/jammr/2026/v38i66151
Pancreatic ductal adenocarcinoma is a highly aggressive malignancy characterized by late diagnosis, rapid progression, and poor survival outcomes. Despite its higher incidence in older men, typically between the ages of 60 and 85, rising rates among younger populations and an inc...
Open access
Research Article10.9734/jammr/2026/v38i46125
The pharmaceutical industry faces profound challenges in its quest to develop novel, safe, and efficacious therapeutics. Traditional drug discovery pipelines are characterised by astronomical costs, protracted timelines, and high attrition rates, with the average cost of bringing...
Open access
Research Article10.9734/jamps/2026/v28i4856
Natural products remain a cornerstone of drug discovery, providing structurally diverse bioactive compounds with significant therapeutic potential. Their incorporation into nanomedicine, either as active pharmaceutical ingredients or functional excipients, has expanded rapidly du...
Open access
Research Article10.9734/jamps/2026/v28i6864
The most important problems in the follow-up of thyroid nodules are missing cancer cases or performing unnecessary thyroidectomy. The aim of this study is to create a more sensitive, risk free and cost-effective algorithm in the follow-up of thyroid nodules. For this purpose, the...
Open access
Research Article10.9734/ajrre/2021/v4i136